MedKoo Cat#: 526157 | Name: Ro 16-6491

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Ro 16-6491 is a selective, reversible, orally-active MAO-B inhibitor.

Chemical Structure

Ro 16-6491
Ro 16-6491
CAS#87235-61-8

Theoretical Analysis

MedKoo Cat#: 526157

Name: Ro 16-6491

CAS#: 87235-61-8

Chemical Formula: C9H12Cl2N2O

Exact Mass: 234.0327

Molecular Weight: 235.11

Elemental Analysis: C, 45.98; H, 5.14; Cl, 30.16; N, 11.92; O, 6.80

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Ro 16-6491; Ro166491; Ro-16-6491.
IUPAC/Chemical Name
N-(2-Aminoethyl)-4-chlorobenzamide hydrochloride
InChi Key
ARUMZUNJBHSOQQ-UHFFFAOYSA-N
InChi Code
InChI=1S/C9H11ClN2O.ClH/c10-8-3-1-7(2-4-8)9(13)12-6-5-11;/h1-4H,5-6,11H2,(H,12,13);1H
SMILES Code
O=C(NCCN)C1=CC=C(Cl)C=C1.[H]Cl
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 235.11 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: DeJesus OT, Flores LG, Roberts AD, Dick DW, Bartlett RM, Murali D, Nickles RJ. Aromatic L-amino acid decarboxylase (AAAD) activity in rhesus macaque striatum after MAO-B inhibition by Ro 16-6491. Synapse. 2005 Apr;56(1):54-6. PubMed PMID: 15700282. 2: Mullan EL, Williams CH. Kinetics of inhibition of MAO-B by N-(2-aminoethyl)-p-chlorobenzamide (Ro 16-6491) and analogues. J Neural Transm Suppl. 1994;41:307-11. PubMed PMID: 7931243. 3: Annan N, Silverman RB. New analogues of N-(2-aminoethyl)-4-chlorobenzamide (Ro 16-6491). Some of the most potent monoamine oxidase-B inactivators. J Med Chem. 1993 Nov 26;36(24):3968-70. PubMed PMID: 8254625. 4: Cesura AM, Imhof R, Muggli-Maniglio D, Picotti GB, Da Prada M. Characterization of [3H]Ro 16-6491 binding to digitonin solubilized monoamine oxidase-B and purification of the enzyme from human platelets by affinity chromatography. Biochem Pharmacol. 1990 Jan 1;39(1):216-20. PubMed PMID: 2297358. 5: Cesura AM, Imhof R, Galva MD, Kettler R, Da Prada M. Interactions of the novel inhibitors of MAO-B Ro 19-6327 and Ro 16-6491 with the active site of the enzyme. Pharmacol Res Commun. 1988 Dec;20 Suppl 4:51-61. PubMed PMID: 3244727. 6: Cesura AM, Imhof R, Takacs B, Galva MD, Picotti GB, Da Prada M. [3H]Ro 16-6491, a selective probe for affinity labelling of monoamine oxidase type B in human brain and platelet membranes. J Neurochem. 1988 Apr;50(4):1037-43. PubMed PMID: 3126263. 7: Cesura AM, Galva MD, Imhof R, Da Prada M. Binding of [3H]Ro 16-6491, a reversible inhibitor of monoamine oxidase type B, to human brain mitochondria and platelet membranes. J Neurochem. 1987 Jan;48(1):170-6. PubMed PMID: 3794699. 8: Keller HH, Kettler R, Keller G, Da Prada M. Short-acting novel MAO inhibitors: in vitro evidence for the reversibility of MAO inhibition by moclobemide and Ro 16-6491. Naunyn Schmiedebergs Arch Pharmacol. 1987 Jan;335(1):12-20. PubMed PMID: 3574489. 9: Da Prada M, Kettler R, Keller HH, Bonetti EP, Imhof R. Ro 16-6491: a new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP. Adv Neurol. 1987;45:175-8. PubMed PMID: 2881442.